Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALNY vs GSK✓SelectedUSD · GSKALNY vs GSK performance historyLatest closeAs of-1.06%11/19
Stock and ETF performance explorer

ALNY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-49.8%
GSK return
-3.4%
Excess return
-46.3%
Maximum drawdown
-54.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-1.6%+0.5%-0.1%
7D-5.6%-4.7%-0.9%-2.8%
30D-35.9%-4.7%-31.2%-34.1%
3M-39.1%-8.8%-30.3%-34.9%
6M-49.8%-4.6%-45.1%-47.2%
All-49.8%-3.4%-46.3%-47.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling